Literature DB >> 7325974

The structure of heparin oligosaccharide fragments with high anti-(factor Xa) activity containing the minimal antithrombin III-binding sequence. Chemical and 13C nuclear-magnetic-resonance studies.

B Casu, P Oreste, G Torri, G Zoppetti, J Choay, J C Lormeau, M Petitou, P Sinäy.   

Abstract

The chemical composition and the 13C n.m.r. spectra of heparin oligosaccharides (essentially octasaccharides), having high affinity for antithrombin III and high anti-(Factor Xa) activity, prepared by three independent approaches (extraction, partial deaminative cleavage with HNO2 and partial depolymerization with bacterial heparinase), leading to different terminal residues, have been studied and compared with those of the corresponding inactive species. Combined wit chemical data, the spectra of the active oligosaccharides and of their fragmentation products afforded information on composition and sequence. The three types of active oligosaccharides were shown to have the common hexasaccharide core I-Aa-G-As*-Is-As, where I and alpha-L-idopyranosyl-uronic acid, Aa = 2-acetamido-2-deoxy-alpha-D-glucopyranose, G = beta-D-glucopyranosyl-uronic acid, Is = alpha-L-idopyranosyluronic acid 2-O-sulphate, As = 2-deoxy-2-sulphamino-alpha-D-glucopyranose 6-O-sulphate. The fourth residue (As*) is an unusually substituted amino sugar resistant to mild deamination. The 13C spectra of the active species are characterized by signals from the above atypical amino sugar, the most evident of which is at 57.7 p.p.m. These signals, compared with those of appropriate synthetic model compounds, are compatible with the recently proposed 3-O-sulphation of the residue As* [Lindahl, Bäckström, Thunberg & Leder (1980) Proc. Natl. Acad. Sci. U.S.A. 77, 6551-6555].

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7325974      PMCID: PMC1163171          DOI: 10.1042/bj1970599

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  28 in total

1.  A modified uronic acid carbazole reaction.

Authors:  T BITTER; H M MUIR
Journal:  Anal Biochem       Date:  1962-10       Impact factor: 3.365

2.  The degradation of heparin by bacterial enzymes. I. Adaptation and lyophilized cells.

Authors:  E D KORN; A N PAYZA
Journal:  J Biol Chem       Date:  1956-12       Impact factor: 5.157

3.  Preparation of potassium 2-deoxy-2-[35S]sulphoamino-D-glucose.

Authors:  F S Wusteman; N Tudball; K S Dodgson
Journal:  Biochem J       Date:  1964-07       Impact factor: 3.857

4.  The antithrombin-binding sequence of heparin studied by n.m.r. spectroscopy.

Authors:  B Meyer; L Thunberg; U Lindahl; O Larm; I G Leder
Journal:  Carbohydr Res       Date:  1981-01-15       Impact factor: 2.104

5.  [Low molecular weight oligosaccharides active in plasma against factor Xa (author's transl)].

Authors:  J Choay; J C Lormeau; M Petitou
Journal:  Ann Pharm Fr       Date:  1981-05

6.  Anti-Xa active heparin oligosaccharides.

Authors:  J Choay; J C Lormeau; M Petitou; P Sinay; B Casu; P Oreste; G Torri; G Gatti
Journal:  Thromb Res       Date:  1980 May 1-15       Impact factor: 3.944

7.  The molecular size of the antithrombin-binding sequence in heparin.

Authors:  L Thunberg; G Bäckström; H Grundberg; J Riesenfeld; U Lindahl
Journal:  FEBS Lett       Date:  1980-08-11       Impact factor: 4.124

8.  Structure of the antithrombin-binding site in heparin.

Authors:  U Lindahl; G Bäckström; M Höök; L Thunberg; L A Fransson; A Linker
Journal:  Proc Natl Acad Sci U S A       Date:  1979-07       Impact factor: 11.205

9.  Quantitation of glycosaminoglycan hexosamine using 3-methyl-2-benzothiazolone hydrazone hydrochloride.

Authors:  R L Smith; E Gilkerson
Journal:  Anal Biochem       Date:  1979-10-01       Impact factor: 3.365

10.  Evidence for a 3-O-sulfated D-glucosamine residue in the antithrombin-binding sequence of heparin.

Authors:  U Lindahl; G Bäckström; L Thunberg; I G Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1980-11       Impact factor: 11.205

View more
  43 in total

1.  Clotting for the Clinician: An Overview of Thrombosis and Antithrombotic Therapy.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1995       Impact factor: 2.300

Review 2.  Implication of GnT-V in cancer metastasis: a glycomic approach for identification of a target protein and its unique function as an angiogenic cofactor.

Authors:  N Taniguchi; S Ihara; T Saito; E Miyoshi; Y Ikeda; K Honke
Journal:  Glycoconj J       Date:  2001 Nov-Dec       Impact factor: 2.916

3.  Screening for anticoagulant heparan sulfate octasaccharides and fine structure characterization using tandem mass spectrometry.

Authors:  Hicham Naimy; Nancy Leymarie; Joseph Zaia
Journal:  Biochemistry       Date:  2010-05-04       Impact factor: 3.162

4.  Anti-thrombin activities of heparin. Effect of saccharide chain length on thrombin inhibition by heparin cofactor II and by antithrombin.

Authors:  B Bray; D A Lane; J M Freyssinet; G Pejler; U Lindahl
Journal:  Biochem J       Date:  1989-08-15       Impact factor: 3.857

Review 5.  Tissue Engineering at the Blood-Contacting Surface: A Review of Challenges and Strategies in Vascular Graft Development.

Authors:  Daniel Radke; Wenkai Jia; Dhavan Sharma; Kemin Fena; Guifang Wang; Jeremy Goldman; Feng Zhao
Journal:  Adv Healthc Mater       Date:  2018-05-07       Impact factor: 9.933

6.  Heparin resistance in acute coronary syndromes.

Authors:  Jonathan D Rich; John M Maraganore; Edward Young; Rosa-Maria Lidon; Burt Adelman; Paul Bourdon; Supoat Charenkavanich; Jack Hirsh; Pierre Theroux; Christopher P Cannon
Journal:  J Thromb Thrombolysis       Date:  2007-01-13       Impact factor: 2.300

Review 7.  Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  David A Garcia; Trevor P Baglin; Jeffrey I Weitz; Meyer Michel Samama
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

8.  Roles of galactose and sulfate residues in sulfatides for their antagonistic functions in the blood coagulation system.

Authors:  M Kyogashima; T Sakai; J Onaya; A Hara
Journal:  Glycoconj J       Date:  2001-03       Impact factor: 2.916

9.  Unique extracellular matrix heparan sulfate from the bivalve Nodipecten nodosus (Linnaeus, 1758) safely inhibits arterial thrombosis after photochemically induced endothelial lesion.

Authors:  Angélica M Gomes; Eliene O Kozlowski; Vitor H Pomin; Cintia Monteiro de Barros; José L Zaganeli; Mauro S G Pavão
Journal:  J Biol Chem       Date:  2010-01-06       Impact factor: 5.157

Review 10.  Anticoagulation therapy in children.

Authors:  Milind D Ronghe; Christina Halsey; Nicholas J Goulden
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.